When is the deadline for filing claims and how might that deadline influence short‑term stock price movements?

Deadline: The Gross Law Firm has set September 15 2025 as the cut‑off date for shareholders of Capricor Therapeutic (CAPR) to contact the firm and file any class‑action claims.

Trading impact: As the deadline approaches, two short‑term dynamics typically emerge. First, a pulse of buying pressure shows up in the days‑to‑weeks before September 15 as investors who still hold shares during the class period scramble to protect potential rights‑offering or settlement value. This can lift CAPR’s price modestly, especially on relatively low‑volume days when the “rights‑claim” narrative spikes on the ticker‑screen. Second, once the deadline passes, the buy‑side catalyst evaporates; any residual speculative demand fades and the stock often reverts to its underlying fundamentals—i.e., the company’s clinical‑trial outlook, cash‑burn, and broader biotech market tone. Expect a post‑deadline pull‑back or at least a flattening of the prior rally, unless other news (e.g., trial data) sustains momentum.

Actionable take‑away: If you’re already long CAPR, consider adding on modestly now (e.g., on pull‑backs or on‑volume spikes) to capture the pre‑deadline rally, but keep a tight stop just above recent swing‑highs to guard against the inevitable unwind after September 15. Conversely, if you’re short, the pre‑deadline buying may trigger a short‑cover rally; positioning a tight‑range short with a stop just above the pre‑deadline high can profit from the expected post‑deadline decay. Monitor the stock’s 5‑day moving average and volume: a breakout above the 5‑day MA with rising volume often precedes the deadline‑driven surge, while a break below that average after September 15 can signal the start of the corrective phase.